Lv4
590 积分 2023-09-10 加入
Metabolic reprogramming of immune cells in MASH
5个月前
已完结
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
5个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
5个月前
已完结
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
7个月前
已完结
皖公网安备34019202002308
